Buscar
Cronos Group Inc
CRONAñadir a la lista de seguimiento
2.895USD
+0.035+1.22%
Cierre 07-30 16:00（ET）Cotizaciones retrasadas 15 min
1.10BCap. mercado
PérdidaP/E TTM
Más Datos de Cronos Group Inc Compañía
Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.
Información de Cronos Group Inc
Símbolo de cotizaciónCRON
Nombre de la empresaCronos Group Inc
Fecha de salida a bolsaMay 07, 2014
Director ejecutivoGorenstein (Michael Ryan)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 07
Dirección4491 Concession Rd 12
CiudadTORONTO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísCanada
Código postalL0M 1S0
Teléfono14165040004
Sitio Webhttps://thecronosgroup.com/
Símbolo de cotizaciónCRON
Fecha de salida a bolsaMay 07, 2014
Director ejecutivoGorenstein (Michael Ryan)
Ejecutivos de Cronos Group Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael Ryan (Mike) Gorenstein, J.D.
Mr. Michael Ryan (Mike) Gorenstein, J.D.
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
13.21M
+4.56%
Mr. Jason Marc Adler
Mr. Jason Marc Adler
Independent Director
Independent Director
9.88M
--
Mr. Jeffrey David (Jeff) Jacobson
Mr. Jeffrey David (Jeff) Jacobson
Chief Growth Officer
Chief Growth Officer
484.68K
+3.64%
Ms. Anna Shlimak
Ms. Anna Shlimak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
358.60K
+29.12%
Ms. Shannon Buggy
Ms. Shannon Buggy
Senior Vice President, Global Head of People
Senior Vice President, Global Head of People
178.32K
+6.42%
Mr. James (Jim) Rudyk
Mr. James (Jim) Rudyk
Lead Independent Director
Lead Independent Director
--
--
Mr. Murray R. Garnick, J.D.
Mr. Murray R. Garnick, J.D.
Independent Director
Independent Director
--
--
Mr. Terry Doucet
Mr. Terry Doucet
General Counsel and Corporate Secretary
General Counsel and Corporate Secretary
--
--
Mr. Arye Weigensberg
Mr. Arye Weigensberg
Senior Vice President, Head of Research & Development
Senior Vice President, Head of Research & Development
--
--
Mr. Kamran Khan
Mr. Kamran Khan
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael Ryan (Mike) Gorenstein, J.D.
Mr. Michael Ryan (Mike) Gorenstein, J.D.
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
13.21M
+4.56%
Mr. Jason Marc Adler
Mr. Jason Marc Adler
Independent Director
Independent Director
9.88M
--
Mr. Jeffrey David (Jeff) Jacobson
Mr. Jeffrey David (Jeff) Jacobson
Chief Growth Officer
Chief Growth Officer
484.68K
+3.64%
Ms. Anna Shlimak
Ms. Anna Shlimak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
358.60K
+29.12%
Ms. Shannon Buggy
Ms. Shannon Buggy
Senior Vice President, Global Head of People
Senior Vice President, Global Head of People
178.32K
+6.42%
Mr. James (Jim) Rudyk
Mr. James (Jim) Rudyk
Lead Independent Director
Lead Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Cronos Group Inc?
Los cinco principales accionistas de Cronos Group Inc son: Mr. Michael Ryan (Mike) Gorenstein, J.D.
¿Cuántas instituciones poseen acciones de Cronos Group Inc (CRON)?
A fecha de 2026Q1, 377 instituciones poseen acciones de Cronos Group Inc, con un valor de mercado combinado de aproximadamente 61.74M, lo que representa el 16.41% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -12850118.00.
¿Cuál es la mayor fuente de ganancias de Cronos Group Inc?
El 2026Q1, el segmento empresarial Cannabis Flower generó la ganancia más alta para Cronos Group Inc, ascendiendo a 108.48M y representando el 74.00% de la ganancia total.